JPS51101953A - - Google Patents
Info
- Publication number
- JPS51101953A JPS51101953A JP50131323A JP13132375A JPS51101953A JP S51101953 A JPS51101953 A JP S51101953A JP 50131323 A JP50131323 A JP 50131323A JP 13132375 A JP13132375 A JP 13132375A JP S51101953 A JPS51101953 A JP S51101953A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB47417/74A GB1522130A (en) | 1974-11-01 | 1974-11-01 | Cyclopentane derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS51101953A true JPS51101953A (lt) | 1976-09-08 |
Family
ID=10444895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50131323A Pending JPS51101953A (lt) | 1974-11-01 | 1975-10-31 |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS51101953A (lt) |
AU (1) | AU499135B2 (lt) |
BE (1) | BE835169A (lt) |
CH (1) | CH609681A5 (lt) |
DE (1) | DE2548878A1 (lt) |
DK (1) | DK492575A (lt) |
FI (1) | FI753056A (lt) |
FR (1) | FR2289170A1 (lt) |
GB (1) | GB1522130A (lt) |
HU (1) | HU173243B (lt) |
LU (1) | LU73702A1 (lt) |
NL (1) | NL7512817A (lt) |
SE (1) | SE7512206L (lt) |
ZA (1) | ZA756876B (lt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5283721A (en) * | 1976-01-01 | 1977-07-12 | Pfizer | 111deoxyyomegaapentanolprostaglandins |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
-
1974
- 1974-11-01 GB GB47417/74A patent/GB1522130A/en not_active Expired
-
1975
- 1975-10-30 FR FR7533161A patent/FR2289170A1/fr not_active Withdrawn
- 1975-10-31 SE SE7512206A patent/SE7512206L/xx unknown
- 1975-10-31 HU HU75MA2726A patent/HU173243B/hu unknown
- 1975-10-31 LU LU73702A patent/LU73702A1/xx unknown
- 1975-10-31 JP JP50131323A patent/JPS51101953A/ja active Pending
- 1975-10-31 BE BE161517A patent/BE835169A/xx unknown
- 1975-10-31 AU AU86251/75A patent/AU499135B2/en not_active Expired
- 1975-10-31 DE DE19752548878 patent/DE2548878A1/de active Pending
- 1975-10-31 DK DK492575A patent/DK492575A/da unknown
- 1975-10-31 NL NL7512817A patent/NL7512817A/xx not_active Application Discontinuation
- 1975-10-31 ZA ZA00756876A patent/ZA756876B/xx unknown
- 1975-10-31 FI FI753056A patent/FI753056A/fi not_active Application Discontinuation
- 1975-10-31 CH CH1413075A patent/CH609681A5/xx not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5283721A (en) * | 1976-01-01 | 1977-07-12 | Pfizer | 111deoxyyomegaapentanolprostaglandins |
JPS581117B2 (ja) * | 1976-01-01 | 1983-01-10 | フアイザ−・インコ−ポレ−テツド | 11−デオキシ−ω−ペンタノルプロスタグランジン類 |
Also Published As
Publication number | Publication date |
---|---|
FR2289170A1 (fr) | 1976-05-28 |
AU499135B2 (en) | 1979-04-05 |
ZA756876B (en) | 1976-10-27 |
BE835169A (fr) | 1976-04-30 |
CH609681A5 (en) | 1979-03-15 |
DK492575A (da) | 1976-05-02 |
NL7512817A (nl) | 1976-05-04 |
DE2548878A1 (de) | 1976-05-13 |
GB1522130A (en) | 1978-08-23 |
SE7512206L (sv) | 1976-05-03 |
LU73702A1 (lt) | 1976-06-11 |
AU8625175A (en) | 1977-05-26 |
FI753056A (lt) | 1976-05-02 |
HU173243B (hu) | 1979-03-28 |